The development of cerebral malaria (CM) in mice with Plasmodium berghei ANKA infection is under genetic control. Brain gene-expression patterns were investigated in well-defined genetically CM-resistant (CM-R; BALB/c and DBA/2) and CM-susceptible (CM-S; C57BL/6 and CBA/J) mice by use of cDNA microarrays. By combining transcriptional profiling with rigorous statistical methods and cluster analysis, we identified a set of 69 genes that perfectly discriminated between mouse strains and between CM-R and CM-S mice. The analysis of gene ontological terms revealed that the genes that clustered and were related to susceptibility to CM preferentially belonged to some biological process classes, such as those pertaining to immune responses. Using a false discovery rate of 5% and the Welch t test, we identified 31 genes with consistent differential expression between CM-R and CM-S mice. These data indicate that microarray analysis may be useful for identification of candidate genes that are potentially responsible for resistance or susceptibility to mouse CM and suggest that candidate genes identified in mice could be specifically tested in humans for an association with disease severity.
pathogenesis or protection, several genes have been associated with resistance to severe malaria, and genes controlling parasitemia and mild malaria have been mapped [3] [4] [5] [6] . The role that some genes play has been demonstrated in mouse models, and new malaria-resistance genes that have been located in the mouse genome remain to be identified [1, 7] .
To investigate the pathogenesis of CM, several animal models have been established, including mice infected with Plasmodium berghei ANKA (PbA) [7, 8] . Although experimental CM models cannot reproduce all the features of human CM, several observations in mouse CM have been extended and confirmed in human disease. These include behavioral changes, histopathological features in the brain and the retina, biochemical changes in the brain, blood-brain barrier function, immunological responses, and expression of molecules in the brain and the retina [1] .
Inbred mouse strains markedly differ in their susceptibility to Plasmodium infection and disease. In the mouse model of PbA infection, BALB/c and DBA/2 mice were resistant to CM (CM-R), whereas C57BL/6 and CBA/J mice were susceptible to CM (CM-S). This model is initiated by the intraperitoneal (ip) injection of P. berghei ANKA asexual blood stages, and not by the cyclical route, which consists of sporozoite inoculation by mosquitoes [1, 7] . Our working hypothesis was that CM resistance/susceptibility differences may be due to genetic differences that influence gene expression. In particular, since CM is associated with an abnormal increase in proinflammatory immune responses, it is conceivable that genes involved in inflammation are up-regulated.
Global expression analysis of 5053 genes was employed to identify differences in brain gene expression between CM-R (BALB/c and DBA/2) mice and CM-S (C57BL/6 and CBA/J) mice. We report here that CM-R mice and CM-S mice infected with PbA differ in their gene expression and that the geneexpression profile is discriminant of resistance or susceptibility to CM.
MATERIALS AND METHODS
Mouse strains and phenotyping. Six-8-week-old BALB/c, DBA/2 (CM-R strains), C57BL/6, and CBA/J (CM-S strains) female mice were obtained from IFFA CREDO (Charles River Laboratories) and kept in our facilities. Five mice from each strain were infected by ip injection with 10 6 P. berghei ANKA parasitized erythrocytes. Parasitemia was monitored daily by blood smear. The CM-S mice developed a neurological syndrome 6-7 days after parasite inoculation, with a cumulative mortality of 100%. The CM-R mice died of severe anaemia and hyperparasitemia during the third or fourth week of infection [7] .
Organ sampling and histological analysis. Brains were removed from CM-R and CM-S mice when the CM-S mice were found to have developed CM. Brains were completely removed and cut into 2 parts: one part was frozen in RNALater (Qiagen) until RNA analysis, and the other part was embedded in Tissue Tek (Leica), snap frozen in liquid nitrogen, and kept at Ϫ80ЊC until histopathological examination of cryosections. Histological analysis consisted of specific-antibody immunohistochemical analysis for vascular cell adhesion molecule (VCAM)-1 (clone 429; BD Pharmingen) and interferon consensus sequence-binding protein (ISCBP)-1 (C19; TEBU Bio). Afterward, slides were photographed, and protein expression was quantified using LU-CIA software (Nikon) [8] . The anti-ICSBP1-specific immunostaining, however, was not efficient enough for detection, whereas the results were satisfactory for anti-VCAM-1 antibody.
RNA isolation and cDNA microarray hybridizations. Total RNA from brains was extracted using TRIzol reagent (Gibco BRL). The quality of RNA was confirmed by use of a formaldehyde agarose gel, and the concentration of RNA was determined by reading the absorbance at 260/280 nm. Each mRNA sample extracted from an individual sample was run on a single microarray. All microarray procedures were done at our microarray core facility (Technologies Avancées pour la Génome et la Clinique). cDNA microarrays were designed and prepared as described elsewhere [9] . The microarrays used in the present study were composed of 5053 sequences. Polymerase chain reaction (PCR) amplification was performed as described elsewhere [9] , and PCR products were spotted onto nylon membranes (Hybond-N+; Amersham) by use of a GMS-417 arrayer (Affymetrix). Approximately 20% of the genes included in this clone set are represented by 2 or more different cDNA clones, which served as internal controls for assessment of the reproducibility of gene-expression measurements. Microarrays were hybridized with 33 P-labelled probes, first with an oligonucleotide sequence common to all spotted PCR products (5 -TCAC-ACAGGAAACAGCTATGAC-3 ) and then, after stripping, with complex probes made from 5 mg of retrotranscribed total RNA. Probe preparations, hybridizations, and washes were performed as described elsewhere [9] . After 48 h of hybridization, arrays were scanned with a Fuji BAS5000 machine, at a resolution of 25 mm.
Microarray data analysis. Hybridization signals were quantified using ArrayGauge software (version 1.31; Fuji). All images were carefully inspected, and spots with overestimated intensities, because of neighborhood effects, were manually excluded. The data from 1 sample (CBA/J mouse) indicated a lower hybridization quality, so the sample was omitted from subsequent analyses. The data were filtered such that only spots with intensities 2 times greater than the median background in either microarray were used in the analysis, and the signal intensities were then corrected to take into account the amount of spotted DNA and the variability of experimental conditions, as described elsewhere [10] . Of the 5053 spotted clones, we selected clones that had detectable expression levels in at least 80% of the experiments ( ). Unsupervised hierarchical clustern p 2145 ing was used to investigate relationships between samples and relationships between genes. It was applied to log-transformed and median-centered data, using the Cluster and TreeView programs (average linkage clustering using Pearson's uncentered correlation as similarity metric) [11] . Using a supervised support vector machine (SVM) method, we investigated the discrimination between CM-R and CM-S mice on the basis of gene-expression profiles [12] .
Statistical analyses were performed using The Institute for Genomic Research multiexperiment viewer software (version 3.1; available at http://www.tm4.org/mev.html). Figure 1 shows an outline of data analysis. A 1-way analysis of variance (ANOVA) and significant analysis of microarrays (SAM) procedures [13] were applied, to identify strain-and CM-R/CM-S-specific variation in gene expression in the full data set. Welch t statistics were used to compare CM-R and CM-S mice [14] . Multipletest corrections were performed [15] . Schematic outline of stepwise data analysis. A 1-way analysis of variance (ANOVA) was applied to look for strain-and cerebral malaria (CM)-resistant (CM-R)/CM-susceptible (CM-S)-specific variation in gene expression in the full data set. Empirical P values were computed for each gene, by bootstrapping from 10,000 permutations. All genes for which were selected for unsupervised and supervised clusterings. To estimate P ! .05 the accuracy of prediction of the "CM molecular signature," we applied the "1-out-iterative cross-validation" testing procedure developed by the supervised support vector machine (SVM) method. Briefly, the algorithm withholds 1 of the 19 mice samples, builds a training set based only on the remaining samples, and predicts the class of the withheld sample. The process was repeated for each sample, and Fisher's exact test was used to assess the significance of the classification. From the full data set, significant differential gene expression was determined using the significant analysis of microarrays (SAM) method. The SAM algorithm gives an estimate of the false-discovery rate (FDR), which is the proportion of falsepositive results among all of the genes initially identified as differentially expressed. Multiclass and 2-class unpaired SAM procedures were used to identify mouse strain-specific and CM-R/CM-S-specific genes, respectively, on the basis of 10,000 bootstrapped permutations. Missing values were imputed using a K-nearest-neighbor algorithm. The multiple-testing problem was addressed by choosing an FDR of 5%. The significant genes, with differential expression between CM-R and CM-S mice, were extracted from the SAM results by use of the Welch t test for small samples with unequal variances in the 2 groups. Empirical P values were computed for each gene from 10,000 bootstrapped permutations. All genes for which were selected, and we applied an FDR of 5%. HCL, hierarchical clustering.
Gene annotation of all 2145 analyzable genes/expressed sequence tags (ESTs) was performed using Expression Analysis Systematic Explorer (EASE) software [16] . This program, which allows a biological interpretation of gene clusters on the basis of gene ontology (GO) terms, was used to assess whether specific biological pathways were overrepresented among the differentially expressed genes and within specific gene clusters. A score based on Fisher's exact test signified the probability that the prevalence of a particular theme within a cluster was due to chance alone, given the prevalence of that theme in the population of all genes under study. All data are minimum information about a microarray experiment compliant and are available in the ArrayExpress database (http://www.ebi.ac.uk/ arrayexpress/; accession number E-MEXP-370).
RESULTS
To identify genes differentially expressed between CM-S and CM-R mice, we combined unsupervised and supervised clustering methods with several statistical approaches (figure 1). All the CBA/J mice ( ) and C57BL/6 mice ( ) den p 4 n p 5 veloped CM, whereas the BALB/c mice ( ) and DBA/2 n p 5 mice ( ) did not, despite similar levels of parasitemia n p 5 (10.4% ‫ע‬ 6.4%). The mRNA from the 19 different mouse To analyze the overall expression patterns, we used an unsupervised hierarchical clustering method that grouped genes on the vertical axis and samples on the horizontal axis, on the basis of similarity in their expression profiles (figure 2A). The similarities are summarized in a dendrogram in which the pattern and length of the branches reflects the relatedness of the samples (figure 2B). On this basis, 8 of 10 CM-R mice and 9 of 9 CM-S mice were clustered together. The discrimination between CM-R and CM-S mice was highly significant (P ! , Fisher's exact test). We assumed that 2 CM-R mice were .0001 incorrectly classified because of confounding genes, which were not differentially expressed between mouse groups.
We, therefore, performed 1-way ANOVA to look for strainand CM-R/CM-S-specific variation in gene expression in the full data set (figure 1). We generated empirical P values for each gene. Then, we selected all genes for which , and P ! .05 we defined a set of 292 informative genes. We performed further unsupervised hierarchical clustering of samples on the basis of the expression of the selected genes ( figure 2C ). As shown in figure 2D , this procedure successfully classified 10 of 10 CM-R mice and 9 of 9 CM-S mice. All mice of each strain were also correctly classified.
To ascertain the accuracy of the prediction of CM molecular signature, we used a "1-out-iterative cross-validation" testing procedure developed by use of the supervised SVM method. Iteratively, 1 of the 19 mouse samples was removed from the group and was classified on the basis of the correlation between its expression profile and the median profile of samples from CM-R mice and CM-S mice. The prediction was considered to be correct if it corresponded to the actual group. Using this approach, we correctly classified 10 of 10 CM-R mice and 9 of 9 CM-S mice, and we confirmed the results of unsupervised hierarchical clustering.
To search for significant genes on the basis of differential expression between mouse groups, we used more-stringent statistical methods, which controlled for the percentage of genes identified by chance. We applied 2 SAM procedures on the full data set, to pick out mouse strain-specific and CM-R/CM-Sspecific genes (figure 1). Differentially expressed genes were selected by use of a false-discovery rate (FDR) of 5%. Multiclass SAM yielded a list of 50 genes that showed a differential expression between mouse strains. Two-class SAM yielded a list of 40 genes that appeared to be differentially expressed between CM-R and CM-S mice. Twenty-one genes belonged to both lists, indicating that the effect of both strain and CM phenotype was detected. We, therefore, found 69 significant genes that belonged to the preliminary list of 292 informative genes.
Unsupervised hierarchical clustering of samples on the basis of the expression of the 69 significant genes was used to successfully classify all the BALB/c, DBA/2, C57BL/6, and CBA/J mice on the one hand and all the CM-R and CM-S mice on the other hand ( figure 3 ). In the same way, 10 of 10 CM-R mice and 9 of 9 CM-S mice were correctly classified by use of the supervised SVM method. We observed 7 clusters that were either mouse strain specific or CM-R/CM-S specific. Clusters A and E grouped DBA/2 and CBA/J mice versus BALB/c and C57BL/6 mice. Clusters C and G discriminated C57BL/6 and BALB/c mice, respectively. Clusters B, D, and F separated CM-R and CM-S mice.
We further analyzed the genes that we had selected as CM-R/CM-S specific by use of the 2-class SAM (figure 1). The 40 genes were assessed for bias due to mouse strain-specific variation in gene expression. First, using the Welch t test, we searched for genes that were differentially expressed in brain samples from BALB/c and DBA/2 CM-R mice on the one hand and C57BL/6 and CBA/J CM-S mice on the other hand. Then, we took these differences into account when we analyzed differential expression between CM-R and CM-S mice.
We found, among the 40 genes selected as CM-R/CM-S specific, 28 genes, the expression of which was not different between BALB/c and DBA/2 CM-R mice or between C57BL/6 and CBA/J CM-S mice (table 1) . We showed, by use of the Welch t test and an FDR of 5%, that the expression of 11 genes was lower in CM-S mice than in CM-R mice (figure 3, cluster F) and that the expression of 17 genes was higher in CM-S mice than in CM-R mice ( figure 3, clusters B and D) .
We found, among the 40 genes selected as CM-R/CM-S specific, 12 genes, the expression of which was different between either BALB/c and DBA/2 CM-R mice or C57BL/6 and CBA/ J CM-S mice (table 2). Using the Welch t test and an FDR of 5%, we found that the expression of Icsbp1 and Vcam-1 was lower in CM-R mice than in C57BL/6 and CBA/J CM-S mice and that the expression of Ccl27 was higher in CM-S mice than in BALB/c and DBA/2 CM-R mice. The expression of the other genes did not significantly differ between CM-R and CM-S mice (table 2) . In all, we identified 31 genes associated with CM.
The analysis of the GO terms of genes composing the dif- NOTE. Genes are listed following the clustering order in figure 3 . S. cerevisiae, Saccharomyces cerevisiae. MGI, mouse genome informatics. a Positive score, gene expression for CM-susceptible (CM-S) mice was higher than that for CM-resistant (CM-R mice); negative score, gene expression for CM-R mice was higher than that for CM-S mice.
ferent identified clusters, by use of the EASE software, showed an overrepresentation of genes involved in defense response (cluster D, ; cluster F, ) and immune response P ! .0004 P ! .008 (cluster D, ), compared with that for the population P ! .0002 of all genes under study. For instance, cluster D contains Samhd1, Serping1, Icsbp1, C1qb, Ifit3, and Ccl27, which are annotated with the "immune response" GO term.
By immunochemical analysis, we further analyzed the expression of Vcam-1, which is a TNF-induced gene. We found that VCAM-1 protein was significantly overexpressed in brain microvessels of CM-S mice, compared with those of CM-R mice (figure 4).
DISCUSSION
By combining transcriptional profiling with rigorous statistical methods and cluster analysis, we searched for differences in brain gene expression between CM-S (C57BL/6 and CBA/J) mice and CM-R (BALB/c and DBA/2) mice. We used 5 biological replicates/group, to take into account variability between mice. This allowed us to search for genes that show small but significant changes in expression and that may be biologically important. The approach used by others was, rather, to perform 1 or 2 microarrays for each condition or to pool the samples, to minimize the experimental variability. Moreover, the selection of genes is generally based on nonstatistically motivated criteria, such as a 2-fold change [17] [18] [19] . On the basis of an FDR of 5%, we identified a set of 69 genes, the expression of which was significantly different between mouse strains and/ or between CM-R and CM-S mice. Cluster analysis showed that this set of genes fully discriminated between mouse strains and between CM-R and CM-S mice.
Since several mouse malaria-resistance loci have been mapped, we looked at the chromosomal localization of the selected genes. Of the 69 selected genes, 67 had a reliable chromosomal lo- cation-the other 2 had missing data corresponding to 2 ESTs. Of the 67 genes, several were located at chromosomal regions previously shown to contain susceptibility loci for CM caused by PbA. Usf1 and Pafah1b1 were located at the chromosome 1 region and the chromosome 11 region, which contain Berr1 and Berr2, respectively [20] . In addition, Nfatc1 and Egr1 were located at chromosome 18, which harbors the locus Esmr, which also controls resistance to mouse CM [21] . We also found that Igf2r, Fkbp5, Lst1, and H2-D1 were located at the chromosome 17 region, which harbors the Cmcs locus [22] . Interestingly, the same chromosome 17 region was reported to contain genes controlling resistance to P. chabaudi (Char3) [23] . Moreover, 3 other chromosomal regions containing a locus controlling resistance to P. chabaudi-namely, Char1 (chromosome 9), Char2 (chromosome 8), and Char4 (chromosome 3)-contained Tcf12, Sntb2, Fnta, Icsbp1, and Vcam-1, which we found to be differentially expressed between CM-R and CM-S mice [23] . It should be stressed that the chromosomal regions linked to malaria resistance are large. Therefore, microarray analyses should be helpful in identifying candidate genes that lie within those genetic regions and that show a differential expression between CM-R and CM-S mice. Cis-acting polymorphisms may affect both gene-expression levels and CM resistance. We identified a cluster of genes up-regulated in C57BL/6 CM-S mice, compared with CM-R mice and CBA CM-S mice. This finding is consistent with the data that indicate that some CM mediators partly differ between CBA and C57BL/6 mice. In particular, it is thought that tumor necrosis factor (TNF) may be a critical mediator of CM in CBA mice [24] , whereas lymphotoxin a may be a critical mediator of CM in C57BL/6 mice [25] . In the same way, we identified a cluster of genes specifically up-regulated in BALB/c CM-R mice, suggesting that some CM-R genetic factors may differ between BALB/c and DBA/2 CM-R mice.
We identified 3 gene clusters associated with resistance or susceptibility to CM. Using the Welch t test and multiple-test correction, we further confirmed that the expression of 31 genes significantly differed between CM-R and CM-S mice. This finding suggests that these genes and related physiological pathways may be critical in malaria pathogenesis in mice. To explore the possible functional role of these genes, we analyzed the occurrence of the GO terms within the clusters. EASE analysis revealed that the genes that clustered preferentially belonged to the 2 following biological process classes: defense response and immune response. Interestingly, the GO terms are organized in a hierarchical way [26] , and the overrepresented terms within the clusters of interest were related. Indeed, a number of known genes involved in the immune system and in the proinflammatory response had expression associated with either resistance or susceptibility to CM.
In particular, Gzmb, Igf2r, Ctla2a, and C1qb were found to be up-regulated in CM-S mice. Gzmb (Ctla1) encodes granzyme B in cytotoxic T lymphocytes (CTLs) and NK cells [27, 28] and induces apoptosis by caspase activation. Igf2r has been reported to bind Gzmb and to be essential for CTL-mediated apoptosis [29] . This is consistent with the data showing that perforin-deficient C57BL/6 mice are CM-R. This indicates that the perforin/granzyme cytolytic pathway may be a major mechanism employed by CD8 + T cells during CM [30, 31] . Ctla2a is expressed in mouse activated T cells [32] . C1qb-that is, the complement component 1 b gene-has also been shown to be up-regulated after permanent focal ischemia in mice [33] . In addition, overexpression of cyclooxygenase-2, which is expressed in the brains of mice with CM [34] , leads to selective induction of C1qb expression in the brain [35] . One might expect that the presence of locally produced complement components within the brain is likely to induce a potent inflammatory response and to contribute to brain damage.
Pafhab1, which was down-regulated in CM-S mice, encodes a subunit platelet-activating factor (PAF) acetylhydrolase, which regulates the level of PAF in the brain [36] . It has been suggested that PAF could play a pathophysiological role in severe malaria, through activation of platelets [37] . Platelets that are sequestered in cerebral microvessels are thought to be involved in endothelial cell damage and in malaria pathogenesis [1] .
We identified several genes known to be related to interferon (IFN) or TNF responses. Samhd1, Ifit3, and Lst1 are IFN-reg-ulated genes [38] [39] [40] , and Icsbp1 and Stat1 are important components of the cellular response to IFN-g. NFATC1 binds to ICSBP1 to promote the transcription of Il12B [41] and to EGR-1 to promote the transcription of Tnf and Il2 [42] . Vcam-1 and Ccl27 are TNF-induced genes [43, 44] , whereas Fkbp5 encodes a heat-shock protein 90-binding immunophilin implicated in the TNF signal transduction pathway [45] . We found that levels of expression of Samhd1, Ifit3, Icsbp1, Stat1, Nfatc1, Fkbp5, and Vcam-1 were nominally higher in the brains of CM-S mice than in the brains of CM-R mice. We analyzed the expression of Vcam-1, to validate the DNA microarray data by use of an immunochemical method. The results confirmed the correlation between the level of expression of Vcam-1 and susceptibility to CM. In the same way, Lou et al. [46] showed that TNF induced a higher level of expression of intercellular adhesion molecule-1 and VCAM-1 in CBA/J (CM-S) brain microvascular endothelial cells (MVECs) than in BALB/c (CM-R) MVECs. In addition, Sexton et al. [47] recently showed that IFN-regulated gene transcripts or IFN regulatory factors, such as Stat1, were strongly increased in the brains of C57BL/6 (CM-S) mice infected with PbA. These results are in line with the current knowledge of the physiological pathways involved in malaria pathogenesis. The role that IFN-g, TNF, and their receptors play in mouse CM has been demonstrated by use of neutralizing monoclonal antibody [48] or gene targeting [49] [50] [51] . Moreover, human TNF and IFN-g receptor (R) 1 polymorphisms are associated with susceptibility to CM [52, 53] . High levels of TNF and IFN-g have been measured in patients with severe malaria [48, 54] , and TNF-R2 complex has been observed on the surface of MVECs from humans with CM [1] . NK cells, CD4 + T cells, and gd T cells have been shown to produce IFN-g in in vitro models of P. falciparum infection [55] [56] [57] . In mice, NK T cells or NK cells could be important sources of IFN-g, since the introduction of C57BL/6 (CM-S) strain NKC genes into a BALB/c (CM-R) mouse resulted in increased production of IFN-g, an increased Th1 response, and susceptibility to CM [58] . Here, we have shown that there are gene-expression profiles associated with susceptibility to mouse CM. We have identified several genes whose expression differed significantly between CM-S and CM-R mice. The concordance between our data and those from the literature, with respect to the function of genes, strengthens the validity of our results. This suggests that these genes-or genes involved in the same physiological pathwayare implicated in malaria pathogenesis in mice and can be considered as candidate genes in humans for an association with CM. Microarray analyses should provide new insights into the key genes that govern the response to malaria.
